Figures
Abstract
To determine the prevalence of genital Chlamydia trachomatis (chlamydia) infection, knowledge about chlamydia and experience of previous testing for chlamydia, we carried out a national probability-based survey in emerging adults aged 18–25 years in Croatia in 2021–2022. Participants (n = 1197), members of a national online panel, completed a web-based questionnaire that collected information on socio-demographics, sexual behaviours and knowledge about sexually transmitted infections (STIs). Urine specimens from a sample of sexually experienced participants were self-collected and tested for chlamydia using Cobas 4800 CT/NG test. To achieve broad representativeness of the emerging adult population in the country, we applied post-hoc weighting for gender and age. Multivariable ordinary least squares linear regression was used to determine correlates of knowledge about chlamydia infection and binomial logistic regression to assess correlates of the willingness to test for chlamydia. Among 448 participants who sent in their urine specimens chlamydia prevalence was 2.5% (95% CI 1.2–5.1) in women and 1.0% (0.3–3.2%) in men. A total of 8.0% of women and 4.7% men reported testing for chlamydia prior to the survey. About a quarter of the sample was characterized by not answering correctly any of the six questions related to knowledge about chlamydia, while only 9.6% had five or six correct answers. In the multivariable analysis, significantly higher odds of willingness to test for chlamydia were found in females compared to males (OR = 1.34, p = 0.024), those with better knowledge about the infection (OR = 1.11, p = 0.005), and those with lower religiosity (OR = 0.91, p = 0.017). In conclusion, prevalence of chlamydia in emerging adults in Croatia is considerable. Efforts to control this infection should focus on primary prevention and targeted testing combined with effective case management strategies.
Citation: Bozicevic I, Blazic TN, Kosanovic Licina ML, Marijan T, Mestrovic T, De Zan T, et al. (2023) Knowledge about and prevalence of Chlamydia trachomatis in a population-based sample of emerging Croatian adults. PLoS ONE 18(10): e0293224. https://doi.org/10.1371/journal.pone.0293224
Editor: Stefan Grosek, University Medical Centre Ljubljana (UMCL) / Faculty of Medicine, University Ljubljana (FM,UL), SLOVENIA
Received: April 8, 2023; Accepted: October 4, 2023; Published: October 27, 2023
Copyright: © 2023 Bozicevic et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting information files.
Funding: The study was funded by the Croatian Science Foundation, Research Project IP-2019-04 (grant # IP-2019-04-3609). Additional financial support for the biological part of the study (for the purpose of financial compensation for the coordination of sample collection, entering the results into the results application for participants and telephone counseling and informing respondents with positive findings) was provided by the Croatian institute of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Chlamydia trachomatis (chlamydia) infection is one of the most frequent sexually transmitted infections (STIs) in young people and may cause complications such as pelvic inflammatory disease, ectopic pregnancy and infertility in women and epididymitis and epididymo-orchitis in men [1]. This infection is often asymptomatic, particularly in women, and can therefore remain undiagnosed and untreated. According to the World Health Organization (WHO) most recent estimates, prevalence of chlamydia among 15–49 years old population in the WHO European Region in 2016 was 2.7% (2.1–3.5%) [2].
In Croatia, the number of reported cases of chlamydia was declining in the 2011–2021 period, from the highest number of 386 cases in 2014 to 115 cases in 2021 while in this same time-period no new or enhanced chlamydia control activities were implemented at the national level [3]. According to the latest European Centre for Disease Prevention and Control (ECDC) data, chlamydia case notification rate in Croatia was 3.7 per 100,000 population in 2019 while the European Union and the European Economic Area (EU/EEA) average was 157.0 per 100,000 population [4]. Among 26 countries of the European Union and the EU/EEA that reported in the 2015–2019 period, the largest decline in the rate of reported cases was seen in Croatia (53%), compared to an average 6% decline in the EU/EEA countries. Differences in chlamydia reporting rates across Europe reflect availability of appropriate diagnostics, level of testing for chlamydia, data reporting practices of health care providers and intensity of chlamydia control activities [5, 6].
Cross-sectional surveys carried on in a representative sample of the general population can provide estimates of the burden of chlamydia provided that participation bias is not substantial, which is often not the case with household-based surveys of sexual behaviours and prevalence of STIs [7]. Recently, Internet-based surveys on sexual behaviours have been successfully utilised to recruit large samples of young people as Internet provides a private, anonymous setting for participation in research, which is beneficial for studies that involve reporting private and sensitive sexual information [8, 9].
The objective of our study was to determine the prevalence of chlamydia among 18–25 year old people in Croatia, assess the level of knowledge about chlamydia and experience of previous testing for chlamydia, and describe correlates of chlamydia-related knowledge and willingness to provide urine specimen to test for chamydial infection in the survey.
Methods
Participants
Data for this study were collected in a large-scale national sample of emerging Croatian adults. In the late 2021, 1,197 participants aged 18–25 years were surveyed using an online questionnaire. All participants were members of a commercial online panel maintained by an international research company. Such approach was deemed the most feasible and efficient considering the coronavirus disease 2019 (COVID-19) pandemic restrictions and widespread concerns that a household-based survey will yield a low response rate. Two-stage stratification (by region and settlement size) grid was used to randomly draw eligible participants from the panel database. Study response rate was 29%, which is comparable to the response of 32% observed in another national study of emerging adults’ sexual and reproductive health more than a decade ago [10]. To achieve broad representativeness of the emerging adult population in the country, we applied post-hoc weighting for gender and age.
Procedure
Data collection, using computer-assisted web-survey, was carried out in from 19 November 2021 to 31 January 2022. Study design and procedures are in detail described elsewhere [11]. All participants were asked for informed consent before starting an online questionnaire and before participating in the biological part of the research. The questionnaire was originally developed in 2005 to assess knowledge about HIV and STIs, attitudes and beliefs about sexuality, and sexual behaviours of emerging adults [12]. The questionnaire was further validated in 2010, while a couple of recently developed measures were piloted in a sample of university students in 2020. The questionnaires took approximately 20 minutes to complete.
Following the completion of the questionnaire, for which they received a small token of appreciation (5 EUR voucher), participants were again contacted by the research company and offered to participate in a biological part of the study, which included provision of a urine sample for chlamydia testing. Participation in the biological arm of the study was rewarded with a voucher worth 20 EUR. Procedures in the process of sampling and communication with respondents (sending invitations to online questionnaire, testing kit, reminders to participate and view results) were carried out by the research company electronically using the usual way of communicating with panel members according to current regulations and existing standards in this area. The research was conducted in such a way that the anonymity of the participants towards the researchers and third parties was ensured. To preserve anonymity, randomly generated 4-digit codes were used to link biological and behavioral data. Testing kit was mailed via post along with a detailed photo-illustrated instructions and a link to a film about how to collect a urine specimen and check test results on-line. Participants were also provided with a specimen return package with the prepaid postage. Urine samples were mailed to the laboratory of the National Referent Center for the Diagnostics of STIs at the Zagreb Teaching Institute for Public Health “Dr. Andrija Stampar”. Specimens were analysed using Cobas 4800 CT/NG Test (Roche Diagnostics, Mannheim, Germany), which is a nucleic acid amplification test (NAAT) for detection of chlamydia.
Together with the testing kit, participants received a card with a unique code to be used for learning test result. Participant could obtain test results by typing in their personal code on a web page specifically designed for the purpose of the survey. Positive results were linked to information of health care specialists that were recommended to be contacted regarding start of the treatment.
All study procedures were approved by the Ethical Review Board of the Faculty of Humanities and Social Sciences, University of Zagreb (approval number 2019–14) and, for the biological arm, by the Institutional Review Board of the Croatian Institute of Public Health, (approval number 030-02/21-01/6 -381-15-20-3).
Measures
The questionnaire included questions on demographics, sexual behaviours (number of sexual partners and condom use), knowledge about HIV and STIs and previous testing for chlamydia. Knowledge about chlamydia infection was assessed by six questions such as: “A person can get infected by chlamydia only once”; “Most women who are infected with chlamydia have no symptoms”, “In men, genital chlamydia infection can be without symptoms”, “If untreated, genital chlamydia infection can have negative consequences on fertility in men”, “If untreated, genital chlamydia infection can have negative consequences on fertility in women” and “Urogenital chlamydial infection can be detected from urine”. Answers were coded as 0 = incorrect and 1 = correct, and summed to form an additive indicator ranging from 0–6. The composite had acceptable internal consistency (KR-20 = 0.65).
Socio-demographics controls were participant’s education (years of formal education divided by age), participant’s family socioeconomic standing (ranging from 1 = “much worse than average family in the country to 5 = “much better than average family”), participant’s religiosity (i.e., frequency of attending religious ceremonies ranging from 1 = “I am not religious” to 7 = “daily or almost daily”, education of participant’s mother and father (0 = less than college education, 1 = college or university education), and place of residence (0 = urban, 1 = rural/semi-urban).
Analytical strategy
Following descriptive analysis and t-testing for gender differences in key indicators, which were carried out on weighted data, two multivariable regression analysis were carried out: linear regression was used with knowledge about chlamydia infection as dependent variable and binomial logistic regression with willingness to test for chlamydia (non-tested vs. tested participants) as dependent variable. To check for potential underestimation of standard errors due to cluster-based sampling approaching, we first estimated intra-cluster correlation (ICC) in unconditional mixed models with sampling points as random effect. Considering that ICC for knowledge about chlamydia was 0.03 and ICC for testing for infection <0.01, the risk of false positives was judged highly unlikely. The proportion of missing data on indicators of interest was low (up to one percent), with the notable exception of the variable number of sexual partners in the past 12 months, which had 31% of missing responses. Following Little’s test of missing completely at random, which suggested that data were missing in non-systematic manner (χ2(20) = 27.19, p = 0.130), we applied multiple imputation (m = 40) to check the robustness of regression findings [13].
To avoid potential biases associated with an overly liberal approach to the inclusion of control variable, only constructs that have been both conceptually and empirically linked to the outcomes (family socioeconomic background, parents’ education, religiosity, and rural vs. urban place of residence) were included in the regression models, together with the number of sexual partners in the past 12 months as an indicator of sexual risk taking, knowledge about chlamydia, as well as previous testing for the infection [14, 15]. Finally, gender was controlled due to gender-specific sexual socialization of young people and higher levels of health concerns in women, especially in the context of reproductive health, compared to men.
Statistical analysis was carried out using IBM SPSS Statistics for Windows, version 29 (IBM Corp., Armonk, N.Y., USA) (descriptive, bivariate, and multivariable analyses with post-hoc weighting) and jamovi statistical software packages (ICC testing) [16].
Results
Socio-demographic characteristics of the sample are presented in Table 1. Mean age of participants was 21.7 years (SD = 2.21) and 48.3% of participants were female. Reflecting national educational structure, most participants reported that their parents completed secondary education. The majority reported some level of religiosity. Regarding sexual behavior, most participants (74.6%) reported a single sexual partner in the past 12 months. Eight percent had no partners in the same period, while 10.8% reported two and 6.6% three or more sexual partners.
A total of 553 participants (46.3% of the sample) expressed interest to receive urine specimen collection device. The majority (81.0%) returned a urine sample. Of the 448 emerging adults who sent in their urine sample—40.4% (n = 245) of female and 34.3% (n = 203) of male participants -, positive result was obtained in nine participants–seven women (2.5%; 95% CI 1.2–5.1) and two men (1.0%; 0.3–3.2). All nine individuals who tested positive learned about their result. According to the weighted analysis, only 6.3% of participants (8.0% of female and 4.7% of male participants) tested for chlamydia prior to this survey while an additional 7.6% of females and 7.8% of males did not remember.
Knowledge about the infection, which ranged from 0 (no correct answers) to 6 (all sex questions correctly answered), was skewed toward lower knowledge (M = 2.2 SD = 1.65; Median score = 2). About a quarter of the sample was characterized by not a single correct answer, while only 9.6% had five or six correct answers. Most emerging adults either reported no (21.6%) or only three correct answers (21.6%). We observed no substantial gender difference in knowledge about the infection (t(1196 = -1.72, p = 0.086). While approximately one in two respondents knew that infection with chlamydia can have adverse consequences on female and male fertility, only 4.5% of men and 1.9% of women knew that this infection can be acquired more than once in a lifetime. A minority– 24.6% of male and 25.2% of female respondents—knew that the majority of women with chlamydia infection do not have any symptoms.
Correlates of knowledge about and testing for chlamydia
Tables 2 and 3 show correlates of knowledge about chlamydia and of providing urine specimens for testing, respectively, using weighted multivariable regression analysis. The results of multivariable regression analysis suggest that participants who self-reported being tested for chlamydia before this survey had significantly better knowledge about chlamydia (B = 0.87, S.E. = 0.21; p<0.001) compared to those who did not test before.
Table 3 (the upper part) shows the results of testing for correlates of providing a urine sample. Somewhat unexpectedly, none of the independent variables significantly contributed to distinguishing between emerging adults who tested for chlamydia in the current study and those who did not.
In the final step, the two regression analyses were repeated using the dataset in which missing information was replaced by multiple imputation. In the case of knowledge about chlamydia (not shown in a table), ever being testing for the infection remained the sole significant predictor (B = 0.74, S.E. = 0.18, p < 0.001). However, the second analysis resulted in a markedly different pattern of (non-)significant findings (see the lower half of Table 3). With missing data imputed, three significant predictors of testing for chlamydia emerged: gender (OR = 1.34, p = 0.024), knowledge about the infection (OR = 1.11, p = 0.005), and religiosity (OR = 0.91, p = 0.017). While female gender and better knowledge about the infection significantly increased the odds of testing, higher religiosity worked in the opposite direction.
Discussion
The prevalence of chlamydia infection in our study was relatively similar to the prevalence found in nationally representative surveys of sexually experienced adults aged 18–26 years in the EU/EEA countries (3.6%) in women, but lower in men (3.5% in the EU/EEA) [5]. The prevalence found in this survey was substantially lower compared to the last round of nationally representative survey among adults aged 18–25 years in Croatia, which found prevalence of chlamydia of 5.3% in women and 7.3% in men in 2010 [17]. However, that study was household-based, with a lower response rate for testing for chlamydia (32.5%) compared to this round of the survey (46.2%). Comparisons between these two surveys should be made with caution due to differences in the recruitment strategies (previous survey was household-based while this one was internet-based) and the fact that the surveys were not powered to detect a change in prevalence. There is evidence that estimates of chlamydia prevalence might be higher in surveys with lower response rates compared to surveys with higher response rates [5].
Prevalence of chlamydia in our study was similar to the prevalence of 2.99% among 1238 students in the city of Zagreb who were tested for chlamydia as part of a three-year screening conducted in in 2017–2019 [18].
Only a minority of respondents in our survey reported being tested for chlamydia before, which shows low availability of chlamydia testing in Croatia. A substantially higher proportion of respondents aged 16–24 years sampled in the nationally representative survey in Britain (Natsal-3) reported being tested for chlamydia in the year before the survey– 54.2% of women and 34.6% of men, reflecting longer-standing and extensive presence of screening for chlamydia in Britain [19]. Furthermore, in a study on randomly selected 377 women aged 18–25 from Washington State in the US, 53% self-reported chlamydia testing in the preceding year [20].
It is discouraging to observe that those with higher number of partners in the past 12 months were not significantly more likely to provide urine specimens for testing for chlamydia in the survey, which might indicate low perception of risk of infection or the possibility that the survey sampling method did not reach those at higher risk of infection.
In contrast to that, those with better knowledge about chlamydia were significantly more likely to provide urine samples for testing. This shows that interventions focused on increasing knowledge and awareness about chlamydia could lead to better uptake of testing.
There is no organized opportunistic testing for chlamydia in Croatia. ECDC recommends that widespread opportunistic testing or screening of sexually active men and women under 25 years in case of sufficient resources and existence of a monitoring and evaluation system, none of which is in place in Croatia [21]. However, effectiveness of chlamydia screening on lowering chlamydia prevalence, preventing pelvic inflammatory disease, ectopic pregnancy or female infertility has been questioned and is a subject of ongoing debates [22, 23]. Targeted testing combined with effective case management strategies, which includes partner notification, and the emphasis on primary prevention of STIs might be a reasonable way forward for chlamydia control in Croatia [20, 24, 25]. It is also important to consider participation rates in such testing approaches, since de Wit and colleagues showed that they are crucial for reaching (or preserving) cost-effectiveness of nationwide chlamydia screening programs–emphasizing the need for extensive piloting prior to implementation decisions [26].
We found considerable gaps in knowledge about chlamydia among young people. Therefore, there is a need for raising awareness and knowledge in the general population of young people about asymptomatic nature of chlamydia infection and its consequences and the risks of re-infections, which might lead to higher demand for testing [27].
Establishment of online services for chlamydia testing should be also considered as this may address barriers to clinic attendance such as long waiting times, inconvenient opening hours, perceived stigma and travel time or cost. Availability of online services in the community alongside clinic services can increase uptake of STI testing in young people, and in particular those that have lower access to services [28], while the experience from Sweden emphasized behavioural risk profile and antecedent chlamydia test results in users of such services to demonstrate how it can indeed reach a relevant target group [29].
Study limitations
Our findings are impacted by accuracy of self-reporting on sexual behaviours. Although Internet recruitment into surveys has a number of advantages it is affected by the sampling and participation bias, which is especially relevant in research on sexual behaviours due to their private nature. Questions were answered via internet and by self-completion, which should have minimised social desirability bias. Since data collection was done on-line, the survey included population with access to internet via mobile or desktop devices. According to data of the Croatian Bureau of Statistics, 86% of households had access to Internet in 2021, while 97% of people aged 16–24 years used Internet [30].
Regarding chlamydia testing, first catch urine is an adequate specimen for screening high-risk groups such as emerging adults for chlamydia by NAAT [31]. COBAS 4800 test used in our study is validated for first catch urine testing in men and women, while transport media used in the testing procedure ensures cellular quality and improves the sensitivity.
Besides its limitations, the internet-based survey on sexual behaviours, which included self-collection of urine samples and testing for chlamydia in young people in Croatia has proven to be feasible and a lower-cost alternative to a household-based survey. It has also been a powerful tool to update and fill the gap of information concerning the prevalence of chlamydia among emerging adults and knowledge about chlamydia infection.
In conclusion, our study found a considerable prevalence of chlamydia among young people in Croatia and low reported prior testing, which implies a need to strengthen chlamydia control efforts by providing innovative targeted chlamydia screening strategies.
Acknowledgments
The authors would like to express their gratitude to Goran Koletić, Ivan Landripet and Kristina Stepusin Seferovic for their help with data collection.
References
- 1.
Progress report on HIV, viral hepatitis and sexually transmitted infections. Accountability for the global health sector strategies, 2016–2021. Geneva: World Health Organization, 2019.
- 2.
Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Web Annex 1. Key data at a glance. Geneva: World Health Organization, 2021.
- 3.
Infectious disease in Croatia. Croatian health statistics for 2021. Zagreb: Croatian Institute for Public Health, 2022. In Croatian.
- 4.
Chlamydia infection. Annual epidemiological report for 2019. Stockholm: European Center for Disease Prevention and Control, 2022.
- 5. Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and metaanalysis. PLoS One. 2015;10:e011575. pmid:25615574
- 6. Barbaric J, Kuchukhidze G, Seguy N, Vovc E, Babovic MJT, Wi TE, et al. Surveillance and epidemiology of syphilis, gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020. Euro Surveill. 2022;27(8):2100197. pmid:35209970
- 7. Copas AJ, Johnson AM, Wadsworth J. Assessing participation bias in a sexual behaviour survey: implications for measuring HIV risk. AIDS. 1997;11(6):783–790. pmid:9143611
- 8.
Roath OK, Chen X, Kolacz. Predictors of Participation for Sexuality Items in a U.S. Population-Based Online Survey. Arch Sex Behav 2023; Online ahead of print
- 9. Evans JR, Mathu A. The value of online surveys: A look back and a look ahead. Internet Research. 2018;28:854–887.
- 10. Landripet I, Stulhofer A, Bacak V. Changes in human immunodeficiency virus and sexually transmitted infections-related sexual risk taking among young Croatian adults: 2005 and 2010 population-based surveys. Croat Med J. 2011;52(4):458–68. pmid:21853540
- 11. Landripet I, Bozicevic I, Bacak V, Stulhofer A. Changes in sexually transmitted infections-related sexual risk taking among young Croatian adults: a 2005–2021 three-wave population-based study. Croat Med J. 2023;64:186–197. pmid:37391916
- 12. Stulhofer A, Graham C, Bozicevic I, Kufrin K, Ajdukovic D. HIV/AIDS-related knowledge, attitudes and sexual behaviors as predictors of condom use among young adults in Croatia. Int Fam Plan Perspect. 2007;33:58–65. pmid:17588849
- 13. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8:206–13. pmid:17549635
- 14. Bernerth JB, Aguinis H. A critical review and best-practice recommendations for control variable usage. Personnel Psychology. 2016;69:229–83.
- 15.
Spector PE, Brannick MT. Methodological urban legends: The misuse of statistical control variables. In Boyle GJ, O’Gorman JG, Fogarty GJ (Eds.). Work and organisational psychology: Research methodology; Assessment and selection; Organisational change and development; Human resource and performance management; Emerging trends: Innovation/globalisation/technology (pp. 63–86). Sage Publications, Inc., 2016.
- 16.
The jamovi project, 2021. jamovi. (Version 2.3.21) [Computer Software]. Feb. 2, 2023 https://www.jamovi.org.
- 17. Bozicevic I, Grgic I, Zidovec-Lepej S, Cakalo JI, Belak-Kovacevic S, Stulhofer A, et al. Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: Feasibility and prevalence. BMC Public Health 2011;11:230.
- 18.
De Zan T, Vranes J, Marijan T, Kvaternik Celjak M, Cesic S, Posavec M, et al. Results of a three-year screening for Chlamydia trachomatis and Mycoplasma genitalium in the student population in Zagreb, Croatia. Abstracts of the 13th Croatian Congress on Clinical Microbiology and the 10th Croatian Congress on Infectious Diseases. Sibenik, Croatia, 20–23 October 2022. In Croatian.
- 19. Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382:1795–1806. pmid:24286785
- 20. Khosropour CM, Broad JM, Scholes D, Saint-Johnson J, Manhart LE, Golden MR. Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures. Sex Transm Dis. 2014;41(11):665–70. pmid:25299413
- 21.
Guidance on chlamydia control in Europe. Scientific advice. Stockholm: European Centre for Disease Prevention and Control, 2005.
- 22. Low N, Hocking JS, Bergen J. The changing landscape of chlamydia control strategies. Lancet. 2021;398:1386–1388. pmid:34562393
- 23. Velicko I, Ploner A, Sparen P, Herrmann B, Marions L, Kuhlmann-Berenzon S. Changes in the Ttrend of sexually acquired chlamydia infections in Sweden and the role of testing: A Time Series Analysis. Sex Transm Dis. 2021;48:329–334.
- 24. Bergen JEAM, Hoenderboom BM, David S, Deug F, Heijne M, Aar F. Where to go to in chlamydia control? From infection control towards infectious disease control. Sex Transm Infect. 2021;97:501–506. pmid:34045364
- 25. Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333–348. pmid:26608577
- 26. de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, et al. Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands. Sex Transm Infect. 2015;91(6):423–9. pmid:25759475
- 27. Sagor RS, Golding J, Giorgio MM, Blake DR. Power of knowledge: Effect of two educational interventions on readiness for chlamydia screening. Clin Ped. 2016;55:717–723. pmid:26350429
- 28. Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson SA et. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14: e1002479.
- 29. Grandahl M, Mohammad J, Larsson M, Herrmann B. Users’ Opinions of Internet-based Self-sampling Tests for Chlamydia trachomatis and Neisseria gonorrhoeae in Sweden. Acta Derm Venereol. 2020;100(18):adv00315. pmid:33104232
- 30.
Usage of information and communication technologies in households and by individuals in 2021. Croatian Bureau of Statistics, 2021. https://podaci.dzs.hr/2021/hr/10262 Accessed on 3 March 2023. In Croatian.
- 31. Haugland S, Thune T, Fosse B, Wentzel-Larsen T, Hjelmevoll SO, Myrmel H. Comparing urine samples and cervical swabs for chlamydia testing in a female population by means of strand displacement assay. BMC Women’s Health. 2010;10:9.